The roundtable panelists provide an historical overview of the DREAMM-7 and DREAMM-8 trials in multiple myeloma.
The panel was moderated by Dr. Saad Usmani, chief of myeloma service at Memorial Sloan Kettering Cancer Center, along with panelists Dr. Meletios A. Dimopoulos, professor and chairman of the department of clinical therapeutics at the National and Kapodistrian University of Athens School of Medicine, Dr. Hans Lee, director of myeloma research at the Sarah Cannon Research Institute, and Dr. Ajay Nooka is a clinical member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University.
Leave feedback about this